These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3898978)

  • 1. Platelet sensitivity to prostacyclin in diabetes mellitus.
    Pillay PK; Pillay U; Balasubramaniam P; Lee KO
    Ann Acad Med Singap; 1985 Apr; 14(2):229-31. PubMed ID: 3898978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets from diabetic subjects show diminished sensitivity to prostacyclin.
    Betteridge DJ; El Tahir KE; Reckless JP; Williams KI
    Eur J Clin Invest; 1982 Oct; 12(5):395-8. PubMed ID: 6816610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular prostacyclin, platelet sensitivity to prostaglandins and platelet-specific proteins in diabetes mellitus. Analysis of type of diabetes, state of metabolic control and diabetic microangiopathy.
    Schernthaner G; Sinzinger H; Silberbauer K; Freyler H; Mühlhauser I; Kaliman J
    Horm Metab Res Suppl; 1981; 11():33-43. PubMed ID: 6459282
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased platelet malondialdehyde, but normal platelet sensitivity to adenosine-5-diphosphate and prostacyclin in well-controlled type 1 diabetics without vascular complications.
    Gisinger C; Schernthaner G
    Diabetes Res; 1986 Oct; 3(8):401-5. PubMed ID: 3545622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased sensitivity of platelets to prostacyclin in patients with diabetes mellitus.
    Akai T; Naka K; Okuda K; Takemura T; Fujii S
    Horm Metab Res; 1983 Nov; 15(11):523-6. PubMed ID: 6360841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet sensitivity in vitro to adenosine-5'-diphosphate and prostacyclin and diabetic retinopathy.
    Davis TM; Bown E; Turner RC
    Diabetologia; 1985 May; 28(5):274-6. PubMed ID: 3894139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H; Hirata T; Sugawara H; Sugai K; Yoda B; Toyota T; Goto Y
    Tohoku J Exp Med; 1982 Aug; 137(4):423-8. PubMed ID: 6750843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of platelet aggregation in diabetics using the new electronic platelet aggregometer.
    Jones RJ; Delamothe AP; Curtis LD; Machin SJ; Betteridge DJ
    Diabet Med; 1985 Mar; 2(2):105-9. PubMed ID: 2952392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage.
    Janka HU; Standl E; Schramm W; Mehnert H
    Diabetes; 1983 May; 32 Suppl 2():47-51. PubMed ID: 6086025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)].
    Klein K; Sinzinger H; Schernthaner G; Silberbauer K; Prager R
    Wien Klin Wochenschr; 1981 Jul; 93(14):460-2. PubMed ID: 7023074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
    Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
    Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic pregnancies.
    Gerö G; Rákóczi I; Tihanyi K; Oláh J; Demeter J; Gáti I
    Haemostasis; 1985; 15(6):377-83. PubMed ID: 3908235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Musiał J; Pietoń R; Mruk J
    Pharmacol Res Commun; 1978 Jun; 10(6):545-56. PubMed ID: 358212
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
    Katsube N; Sakaguchi K; Fujitani B; Aishita H
    Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: a response similar to that observed in adults.
    Varela AF; Runge A; Ignarro LJ; Chaudhuri G
    Am J Obstet Gynecol; 1992 Dec; 167(6):1599-604. PubMed ID: 1471673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM; Macagni A; Pozza G
    Horm Metab Res; 1989 Nov; 21(11):616-8. PubMed ID: 2480323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction of heparin with ADP and prostacyclin on rat platelets.
    Roncaglioni MC; Bertelé V; de Gaetano G; Donati MB
    Thromb Res; 1983 Jul; 31(2):397-400. PubMed ID: 6356460
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.